Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013). (Q38106734)

29 August 2017

title

Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013). (English)

1 reference

29 August 2017

3

1 reference

29 August 2017

Simona Maria Monti

1

0 references

Claudiu T Supuran

series ordinal

2

object named as

Claudiu T Supuran

1 reference

29 August 2017

language of work or name

English

0 references

publication date

15 May 2013

1 reference

Expert Opinion on Therapeutic Patents

29 August 2017

published in

1 reference

29 August 2017

volume

23

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

737-749

1 reference

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Cancer-associated carbonic anhydrases and their inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase IX as a target for designing novel anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Regulation of tumor pH and the role of carbonic anhydrase 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Causes and consequences of tumour acidity and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Hypoxia in cancer cell metabolism and pH regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

The role of carbonic anhydrase IX overexpression in kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrases as drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Sulfonamides: a patent review (2008 - 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Direct screening of natural product extracts using mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Modulation of carbonic anhydrase activity and its applications in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

Carbonic anhydrase inhibitors — Part 53. Synthesis of substituted-pyridinium derivatives of aromatic sulfonamides: The first non-polymeric membrane-impermeable inhibitors with selectivity for isozyme IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.798648

10.1517/13543776.2013.798648

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference